Maarten van der Linden
4PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Nov 30, 2023
Anti-citrullinated histone monoclonal antibody CIT-013, a dual action therapeutic for neutrophil extracellular trap-associated autoimmune diseases.Maarten van der Linden, Sangeeta Kumari, Daphne Montizaan
|Sep 17, 2021
Signal inhibitory receptor on leukocytes-1 recognizes bacterial and endogenous amphipathic α-helical peptides.Matevž Rumpret, Helen J von Richthofen, Maarten van der Linden
|Jun 19, 2021
Recognition of S100 proteins by Signal Inhibitory Receptor on Leukocytes-1 negatively regulates human neutrophils.Matevž Rumpret, Helen J von Richthofen, Maarten van der Linden
|Mar 24, 2020
Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases.Renato G S Chirivi, Jos W G van Rosmalen, Maarten van der Linden
Pageof 1
Frequent Collaborators
2 joint publications
Renato G S Chirivi
2 joint publications
Matevž Rumpret
2 joint publications
Helen J von Richthofen
2 joint publications
Cami Talavera Ormeño
2 joint publications
Linde Meyaard
1 joint publications
Markus H Hoffmann
1 joint publications
Teck Y Low
1 joint publications
Jos A G van Strijp
1 joint publications
Meytal Landau
1 joint publications
Nina M van Sorge
